Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

NOXXON Pharma AG

NOXXON Pharma AG is an independent biopharmaceutical company focusing on the development of innovative pharmaceutical products based on its unique proprietary Spiegelmer® Technology. 

NOXXON's goal is the in-house development of our own Spiegelmer products through Phase II clinical trials. Complementing its own programs, NOXXON works on multiple drug discovery projects. The pursuit of licensing partnerships and collaborative Research & Development efforts is an integral part of our business strategy and plays an important role in the company's growth and success. This strategy reflects our strengths in drug discovery and  the vast potential of our unique technology platform.

Details


Adresse:
NOXXON Pharma AG

Max-Dohrn-Str. 8-10
10589 Berlin
Deutschland
Arbeitsgebiet:
Klinische Forschung
Forschung & Lehre
Sonstige Tätigkeitsfelder
Expansion:
international
Mitarbeiteranzahl:
51-500